The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer

European Journal of Clinical Investigation

Volumn 40, Issue 7, 2010, Pages 591-599

  Kolwijck, Eva ^a   Kos, Janko ^b,c   Obermajer, Natasja ^b,c   Span, Paul N ^a   Thomas, Chris M G ^a   Massuger, Leon F A G ^a   Sweep, Fred C G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Cathepsins; Cyst fluid; Cystatin C; Lysosomal cysteine proteases; Ovarian cancer; Ovarian carcinoma

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; CATHEPSIN X; CYSTATIN C;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYST FLUID; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; OVARY CYST; PREDICTOR VARIABLE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CATHEPSINS; CYST FLUID; CYSTATIN C; FEMALE; HUMANS; MIDDLE AGED; OVARIAN CYSTS; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953523682     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02305.x     Document Type: Article

References (42)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58: 71 96.
2. Naora H. The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms. Expert Rev Mol Med 2007 9: 1 12.
3. Duffy MJ. Proteases as prognostic markers in cancer. Clin Cancer Res 1996 2: 613 618.
4. Turk V, Turk B, Guncar G, Turk D, Kos J. Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv Enzyme Regul 2002 42: 285 303.
5. Kos J, Werle B, Lah T, Brunner N. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers 2000 15: 84 9.
6. Brix K, Dunkhorst A, Mayer K, Jordans S. Cysteine cathepsins: cellular roadmap to different functions. Biochimie 2008 90: 194 207.
7. Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J 2001 20: 4629 4633.
8. Nishida Y, Kohno K, Kawamata T, Morimitsu K, Kuwano M, Miyakawa I. Increased cathepsin L levels in serum in some patients with ovarian cancer: comparison with CA125 and CA72-4. Gynecol Oncol 1995 56: 357 361.
9. Protopapas A, Diakomanolis E, Bamias A, Milingos S, Markaki S, Papadimitriou C et al. The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapy. Eur J Gynaecol Oncol 2004 25: 225 229.
10. Scorilas A, Fotiou S, Tsiambas E, Yotis J, Kotsiandri F, Sameni M et al. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol Chem 2002 383: 1297 1303.
11. Athanassiadou P, Sakellariou V, Petrakakou E, Athanassiades P, Zerva C, Liossi A et al. Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors. Pathol Oncol Res 1998 4: 103 107.
12. Scambia G, Panici PB, Ferrandina G, Salerno G, D'Agostino G, Distefano M et al. Clinical significance of cathepsin D in primary ovarian cancer. Eur J Cancer 1994 30A: 935 940.
13. Kolwijck E, Massuger LF, Thomas CM, Span PN, Krasovec M, Kos J et al. Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors. J Cancer Res Clin Oncol 2010 136: 771 778.
14. Bar JK, Harlozinska A, Sobanska E, Cislo M. Relation between ovarian carcinoma-associated antigens in tumor tissue and detached cyst fluid cells of patients with ovarian neoplasms. Tumori 1994 80: 50 5.
15. Nishikawa H, Ozaki Y, Nakanishi T, Blomgren K, Tada T, Arakawa A et al. The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol 2004 92: 881 886.
16. Zore I, Krasovec M, Cimerman N, Kuhelj R, Werle B, Nielsen HJ et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem 2001 382: 805 810.
17. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010 40: 35 53.
18. Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I et al. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe Seyler 1995 376: 401 405.
19. Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 1997 3: 1815 1822.
20. Schweiger A, Stabuc B, Popovic T, Turk V, Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera. J Immunol Methods 1997 201: 165 172.
21. Kos J, Sekirnik A, Premzl A, Zavasnik B V, Langerholc T, Turk B et al. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp Cell Res 2005 306: 103 113.
22. Servov SF, Scully RE, Sobin LH. International histologic classification of tumors. No. 9: Histologic typing of ovarian tumors.
23. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet 1999 65: 243 249.
24. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 2000 19: 7 15.
25. Staack A, Koenig F, Daniltchenko D, Hauptmann S, Loening SA, Schnorr D et al. Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder. Urology 2002 59: 308 312.
26. Hirano T, Manabe T, Takeuchi S. Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis. Cancer Lett 1993 70: 41 4.
27. Nagai A, Terashima M, Harada T, Shimode K, Takeuchi H, Murakawa Y et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin Chim Acta 2003 329: 53 60.
28. Bunatova K, Obermajer N, Kotyza J, Pesek M, Kos J. Levels of cathepsins S and H in pleural fluids of inflammatory and neoplastic origin. Int J Biol Markers 2009 24: 47 51.
29. Herszenyi L, Istvan G, Cardin R, De PM, Plebani M, Tulassay Z et al. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Eur J Cancer Prev 2008 17: 438 445.
30. Leto G, Tumminello FM, Pizzolanti G, Montalto G, Soresi M, Carroccio A et al. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 1997 14: 22 7.
31. Siewinski M, Saleh Y, Gryboc M, Murawski M, Ekonjo GB, Ziolkowski P et al. Determination of cysteine peptidases-like activity and their inhibitors in the serum of patients with ovarian cancer treated by conventional chemotherapy and vitamin E. J Exp Ther Oncol 2004 4: 189 193.
32. Hirai K, Yokoyama M, Asano G, Tanaka S. Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 1999 30: 680 686. (Pubitemid 29266728)
33. Yano M, Hirai K, Naito Z, Yokoyama M, Ishiwata T, Shiraki Y et al. Expression of cathepsin B and cystatin C in human breast cancer. Surg Today 2001 31: 385 389.
34. Warwas M, Haczynska H, Gerber J, Nowak M. Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma. Eur J Clin Chem Clin Biochem 1997 35: 301 304.
35. Qian F, Chan SJ, Gong QM, Bajkowski AS, Steiner DF, Frankfater A. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors. Biomed Biochim Acta 1991 50: 531 540.
36. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997 59: 63 88.
37. Soslow RA. Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol 2008 27: 161 174.
38. Shih I, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004 164: 1511 1518.
39. Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W et al. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Br J Cancer 2000 82: 782 788.
40. Nagler DK, Kruger S, Kellner A, Ziomek E, Menard R, Buhtz P et al. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate 2004 60: 109 119.
41. Krueger S, Kalinski T, Hundertmark T, Wex T, Kuster D, Peitz U et al. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol 2005 207: 32 42.
42. Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers 2008 23: 161 168.